Mayne Pharma Says Return To Positive EBITDA Expected In FY24

Image Source: ©2022 Kalkine Media®

Nov 30 (Reuters) - Mayne Pharma Group Ltd:

* FOCUSED ON DRIVING IMPROVED PROFITABILITY AND CASH FLOW WITH RETURN TO POSITIVE EBITDA EXPECTED IN FY24 Source text for Eikon: Further company coverage:



 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and